27 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment
8-K
EX-10.1
v8q q430lu6
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
424B3
3e6e4nqfs1cgh0wjdlp
4 Apr 23
Prospectus supplement
4:57pm
POS AM
j2tax6 x6cbq
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
iagxw9nnbz qyfj4
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B4
gghsoqwa
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
dm7h9mr o6tlr1fj0u
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
ag3wupki
2 Jun 21
Draft registration statement
12:00am
DRS
x2ufr043qoww4zdidodk
2 Jun 21
Draft registration statement
12:00am
10-K
bwnfyjn
31 Mar 21
Annual report
2:14pm
424B4
6aqzwk22ks jgqhmq3c
28 Dec 20
Prospectus supplement with pricing info
6:04am